Artiom Cernijenko

Artiom Cernijenko, originally from Lithuania, obtained his BS degree at the University of Oxford. He obtained his MS degree working in the Lab of Prof. Martin Smith at the University of Oxford, exploring enantioselective phase-transfer catalyzed synthesis of nitrogen heterocycles. Artiom pursued his PhD degree in the Lab of Prof. Phil Baran at Scripps Research Institute where he worked on enantioselective synthesis of ent-kaurane diterpene (-)-maoecrystal V. Artiom then joined Global Discovery Chemistry (GDC) group at Novartis in Cambridge, MA, where he has been involved in multiple Targeted Protein Degradation (TPD) projects for oncology, immunology, and hematology indications.